Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4437)
All Articles published online
|
Jul 14, 2008 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Moehler M, Frings C, Mueller A, Gockel I, Schimanski CC, Biesterfeld S, Galle PR, Holtmann MH. VEGF-D expression correlates with colorectal cancer aggressiveness and is downregulated by cetuximab. World J Gastroenterol 2008; 14(26): 4156-4167 [PMID: 18636661 DOI: 10.3748/wjg.14.4156] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i26/4156.htm |
| Number | Citing Articles |
| 1 |
Taner Babacan, Ibrahim Halil Turkbeyler, Muhammet Sait Dag, Ismail Dilli, Ozan Balakan, Kadri Altundag. Cetuximab-induced esophageal ulcer: the first report in literature. Libyan Journal of Medicine 2014; 9(1) doi: 10.3402/ljm.v9.23723
|
| 2 |
M. Moehler, A. Mueller, T. Trarbach, F. Lordick, T. Seufferlein, S. Kubicka, M. Geißler, S. Schwarz, P.R. Galle, S. Kanzler. Cetuximab with irinotecan, folinic acid and 5-fluorouracil as first-line treatment in advanced gastroesophageal cancer: a prospective multi-center biomarker-oriented phase II study. Annals of Oncology 2011; 22(6): 1358 doi: 10.1093/annonc/mdq591
|
| 3 |
Jennifer Ose, Biljana Gigic, Sheetal Hardikar, Tengda Lin, Caroline Himbert, Christy A. Warby, Anita R. Peoples, Clara L. Lindley, Juergen Boehm, Petra Schrotz-King, Jane C. Figueiredo, Adetunji T. Toriola, Erin M. Siegel, Christopher I. Li, Alexis Ulrich, Martin Schneider, David Shibata, Cornelia M. Ulrich. Presurgery Adhesion Molecules and Angiogenesis Biomarkers Are Differently Associated with Outcomes in Colon and Rectal Cancer: Results from the ColoCare Study. Cancer Epidemiology, Biomarkers & Prevention 2022; 31(8): 1650 doi: 10.1158/1055-9965.EPI-22-0092
|
| 4 |
Ying-Bo Li, Zhong-Qing Wang, Xu Yan, Mei-Wan Chen, Jiao-Lin Bao, Guo-Sheng Wu, Ze-Mei Ge, De-Min Zhou, Yi-Tao Wang, Run-Tao Li. IC-4, a new irreversible EGFR inhibitor, exhibits prominent anti-tumor and anti-angiogenesis activities. Cancer Letters 2013; 340(1): 88 doi: 10.1016/j.canlet.2013.07.005
|
| 5 |
Caren Jayasinghe, Nektaria Simiantonaki, Sylvia Habedank, Charles James Kirkpatrick. The relevance of cell type- and tumor zone-specific VEGFR-2 activation in locally advanced colon cancer. Journal of Experimental & Clinical Cancer Research 2015; 34(1) doi: 10.1186/s13046-015-0162-5
|
| 6 |
Pithi Chanvorachote, Varisa Pongrakhananon, Hasseri Halim. Caveolin-1 regulates metastatic behaviors of anoikis resistant lung cancer cells. Molecular and Cellular Biochemistry 2015; 399(1-2): 291 doi: 10.1007/s11010-014-2255-4
|
| 7 |
Ivo Stárek, Richard Salzman, Ladislava Kučerová, Alena Skálová, Lukáš Hauer. Expression of VEGF-C/-D and lymphangiogenesis in salivary adenoid cystic carcinoma. Pathology - Research and Practice 2015; 211(10): 759 doi: 10.1016/j.prp.2015.07.001
|
| 8 |
E. Jubeli, N. Yagoubi, F. Pascale, L. Bédouet, K. Slimani, D. Labarre, J.P. Saint-Maurice, A. Laurent, L. Moine. Embolization biomaterial reinforced with nanotechnology for an in-situ release of anti-angiogenic agent in the treatment of hyper-vascularized tumors and arteriovenous malformations. European Journal of Pharmaceutics and Biopharmaceutics 2015; 96: 396 doi: 10.1016/j.ejpb.2015.09.006
|
| 9 |
Manuela Eppenberger, Inti Zlobec, Daniel Baumhoer, Luigi Terracciano, Alessandro Lugli. Role of the VEGF ligand to receptor ratio in the progression of mismatch repair-proficient colorectal cancer. BMC Cancer 2010; 10(1) doi: 10.1186/1471-2407-10-93
|
| 10 |
Camille Ettelaie, Donna Fountain, Mary Elizabeth W. Collier, Azza M. ElKeeb, Yu Pei Xiao, Anthony Maraveyas. Low molecular weight heparin downregulates tissue factor expression and activity by modulating growth factor receptor-mediated induction of nuclear factor-κB. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2011; 1812(12): 1591 doi: 10.1016/j.bbadis.2011.09.007
|
| 11 |
Thomas Thomaidis, Annett Maderer, Andrea Formentini, Susanne Bauer, Mario Trautmann, Michael Schwarz, Wiebke Neumann, Jens Martin Kittner, Arno Schad, Karl-Heinrich Link, Johannes Wilhelm Rey, Arndt Weinmann, Arthur Hoffman, Peter Robert Galle, Marko Kornmann, Markus Moehler. Proteins of the VEGFR and EGFR pathway as predictive markers for adjuvant treatment in patients with stage II/III colorectal cancer: results of the FOGT-4 trial. Journal of Experimental & Clinical Cancer Research 2014; 33(1) doi: 10.1186/s13046-014-0083-8
|
| 12 |
Connie I. Diakos, Kellie A. Charles, Wei Chua, Viive M. Howell, Stephen J. Clarke. Biomarkers in Cancer. 2014; : 1 doi: 10.1007/978-94-007-7744-6_1-1
|
| 13 |
Chunhui Zhang, Li Hao, Liang Wang, Yichuan Xiao, Hailiang Ge, Zhenya Zhu, Yunbao Luo, Yi Zhang, Yanyun Zhang. Elevated IGFIR expression regulating VEGF and VEGF-C predicts lymph node metastasis in human colorectal cancer. BMC Cancer 2010; 10(1) doi: 10.1186/1471-2407-10-184
|
| 14 |
Robert Coleman, Luis Costa, Fred Saad, Richard Cook, Peyman Hadji, Evangelos Terpos, Patrick Garnero, Janet Brown, Jean-Jacques Body, Matthew Smith, Ker-Ai Lee, Pierre Major, Meletios Dimopoulos, Allan Lipton. Consensus on the utility of bone markers in the malignant bone disease setting. Critical Reviews in Oncology/Hematology 2011; 80(3): 411 doi: 10.1016/j.critrevonc.2011.02.005
|
| 15 |
Annett Maderer, Stanislav Plutizki, Jan-Peter Kramb, Katrin Göpfert, Monika Linnig, Katrin Khillimberger, Christopher Ganser, Eva Lauermann, Gerd Dannhardt, Peter R. Galle, Markus Moehler. Moguntinones—New Selective Inhibitors for the Treatment of Human Colorectal Cancer. Molecular Cancer Therapeutics 2014; 13(6): 1399 doi: 10.1158/1535-7163.MCT-13-0224
|
| 16 |
Orestis Lyros, Annett Mueller, Florian Heidel, Carl C. Schimanski, Ines Gockel, Peter R. Galle, Hauke Lang, Markus Moehler. Analysis of anti‐proliferative and chemosensitizing effects of sunitinib on human esophagogastric cancer cells: Synergistic interaction with vandetanib via inhibition of multi‐receptor tyrosine kinase pathways. International Journal of Cancer 2010; 127(5): 1197 doi: 10.1002/ijc.25137
|
| 17 |
Lixia He, Junyong He, Xia Zhao. Expression of VEGF‐D in epithelial ovarian cancer and its relationship to lymphatic metastasis. Asia-Pacific Journal of Clinical Oncology 2016; 12(1) doi: 10.1111/ajco.12086
|
| 18 |
Carl C. Schimanski, Friederike Schlaegel, Mareike Jordan, Markus Moehler, George Sgourakis, Daniel G. Drescher, Peter R. Galle, Hauke Lang, Ines Gockel. VEGF‐D Correlates with Metastatic Disease in Gastric Cancer Patients Undergoing Surgery. World Journal of Surgery 2011; 35(5): 1010 doi: 10.1007/s00268-011-1041-7
|
| 19 |
M. Pia Morelli, Amy M. Brown, Todd M. Pitts, John J. Tentler, Fortunato Ciardiello, Anderson Ryan, Juliane M. Jürgensmeier, S. Gail Eckhardt. Targeting vascular endothelial growth factor receptor-1 and -3 with cediranib (AZD2171): effects on migration and invasion of gastrointestinal cancer cell lines. Molecular Cancer Therapeutics 2009; 8(9): 2546 doi: 10.1158/1535-7163.MCT-09-0380
|
| 20 |
Aya M. A. Elsayed, Mariam Oweda, Asmaa M. Abushady, Maha Alhelf, Shaimaa R. M. Khalil, Mohamed S. Tawfik, Walid Al-Atabany, Mohamed El-Hadidi. Identification of Differentially Expressed Genes in Human Colorectal Cancer Using RNASeq Data Validated on the Molecular Level with Real-Time PCR. Biochemical Genetics 2024; 62(4): 3260 doi: 10.1007/s10528-023-10593-5
|
| 21 |
Connie I. Diakos, Kellie A. Charles, Wei Chua, Viive M. Howell, Stephen J. Clarke. Biomarkers in Cancer. Biomarkers in Disease: Methods, Discoveries and Applications 2015; : 601 doi: 10.1007/978-94-007-7681-4_1
|
| 22 |
Stephen J. Clarke, Christos S. Karapetis, Peter Gibbs, Nick Pavlakis, Jayesh Desai, Michael Michael, Niall C. Tebbutt, Tim J. Price, Josep Tabernero. Overview of biomarkers in metastatic colorectal cancer: Tumour, blood and patient-related factors. Critical Reviews in Oncology/Hematology 2013; 85(2): 121 doi: 10.1016/j.critrevonc.2012.06.001
|
| 23 |
Steven A. Stacker, Steven P. Williams, Tara Karnezis, Ramin Shayan, Stephen B. Fox, Marc G. Achen. Lymphangiogenesis and lymphatic vessel remodelling in cancer. Nature Reviews Cancer 2014; 14(3): 159 doi: 10.1038/nrc3677
|
| 24 |
V. Moreno García, J. F. Batlle, E. Casado, E. Burgos, J. de Castro, C. Belda, J. Barriuso, J. J. Sánchez, M. Á. García-Cabezas, M. González-Barón, P. Cejas. Immunohistochemical analysis of tumour regression grade for rectal cancer after neoadjuvant chemoradiotherapy. Colorectal Disease 2011; 13(9): 989 doi: 10.1111/j.1463-1318.2010.02386.x
|
| 25 |
Thomas Thomaidis, Annett Maderer, Salah-Eddin Al-Batran, Janis Kany, Claudia Pauligk, Kristina Steinmetz, Arno Schad, Ralf Hofheinz, Harald Schmalenberg, Nils Homann, Peter Robert Galle, Markus Moehler. VEGFR-3 and CXCR4 as predictive markers for treatment with fluorouracil, leucovorin plus either oxaliplatin or cisplatin in patients with advanced esophagogastric cancer: a comparative study of the Arbeitsgemeinschaft Internistische Onkologie (AIO). BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-476
|
| 26 |
M. Moehler, A. Mueller, J.T. Hartmann, M.P. Ebert, S.E. Al-Batran, P. Reimer, M. Weihrauch, F. Lordick, T. Trarbach, S. Biesterfeld, M. Kabisch, D. Wachtlin, P.R. Galle. An open-label, multicentre biomarker-oriented AIO phase II trial of sunitinib for patients with chemo-refractory advanced gastric cancer. European Journal of Cancer 2011; 47(10): 1511 doi: 10.1016/j.ejca.2011.04.006
|
| 27 |
Ping Yan, Hui Gong, Xiaoyan Zhai, Yi Feng, Jun Wu, Sheng He, Jian Guo, Xiaoxia Wang, Rui Guo, Jun Xie, Ren-Ke Li. Decreasing CNPY2 Expression Diminishes Colorectal Tumor Growth and Development through Activation of p53 Pathway. The American Journal of Pathology 2016; 186(4): 1015 doi: 10.1016/j.ajpath.2015.11.012
|
| 28 |
Jiri Hoza, Richard Salzman, Tomas Bakaj, Ladislava Kucerova, Ivo Starek. Comparison of lymphatic vessel density and expression of VEGF-C and VEGF-D lymphangiogenic factors in Warthin's tumours and oncocytic adenomas. Biomedical Papers 2018; 162(1): 47 doi: 10.5507/bp.2017.048
|
| 29 |
J. Nolde, C. deWit, E. Schloericke, H.-P. Bruch, T. Laubert. Regulation of tumor growth and angiogenesis in colorectal cancer. European Surgery 2012; 44(5): 336 doi: 10.1007/s10353-012-0160-1
|
| 30 |
Massimiliano Berretta, Lara Alessandrini, Chiara De Divitiis, Guglielmo Nasti, Arben Lleshi, Raffaele Di Francia, Gaetano Facchini, Carla Cavaliere, Carlo Buonerba, Vincenzo Canzonieri. Serum and tissue markers in colorectal cancer: State of art. Critical Reviews in Oncology/Hematology 2017; 111: 103 doi: 10.1016/j.critrevonc.2017.01.007
|
| 31 |
Hui Ying, Ren-Jun Huang, Xiao-Min Jing, Yan Li, Qun-Qiu Tong. Effect of cetuximab plus FOLFOX4 regimen on clinical outcomes in advanced gastric carcinoma patients receiving evidence-based care. World Journal of Clinical Cases 2024; 12(18): 3360-3367 doi: 10.12998/wjcc.v12.i18.3360
|